Royalcare Super Speciality Hospitals
₹ 160▲0.00%(0.00)
About the company
Royal Care Super Specialty Hospital is one of Coimbatore's leading healthcare institutions, known for delivering high-quality, patient-focused medical care. Established on May 1, 2015, the hospital began its journey as a 50-bed multi-specialty hospital with a vision to provide advanced healthcare services supported by modern technology, experienced medical professionals, and compassionate patient care.
Within a short period, Royal Care earned the trust of patients and referring doctors across western Tamil Nadu through its commitment to clinical excellence, accurate diagnosis, and personalized treatment. The growing demand for its services led to a significant expansion, transforming the hospital into a comprehensive tertiary care center capable of handling complex medical and surgical cases across multiple specialties.
Fundamentals
Valuation
- 52 week high
- ₹160
- 52 week low
- ₹125
- P/B ratio
- 9.21
- Debt to equity
- 1.34
- ROE (%)
- 4.72%
- Book value
- ₹17.37
- Face value
- ₹10
- Valuation
- —
Registry
- ISIN number
- INE02C801010
Figures in cr ·
Financials
| P&L Statement | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 221 | 301 | 305 | 333 | 352 |
| EBITDA | 55 | 68 | 61 | 67 | 52 |
| OPM | 24.89 | 22.59 | 20 | 20.12 | 14.77 |
| PBT | 4 | 21 | 16 | 24 | 16 |
| PAT | 4 | 21 | 16 | 24 | 15 |
| EPS | 0.24 | 1.28 | 0.97 | 1.4 | 0.8 |
Shareholding Pattern
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| Dr. K. Madeswaran | Chairman & MD | 25+ yrs experience | — |
| Dr. K. Chockalingam | Director | 25+ yrs experience | — |
| Sri. T.Balachander | Director & CFO | 25+ yrs experience | — |
Frequently asked questions
Common questions on Royalcare Super Speciality Hospitals—tap a row to read the answer.
Q.1What is Royal Care Super Specialty Hospital?
Royal Care Super Specialty Hospital is a healthcare provider based in Coimbatore, Tamil Nadu, offering multi-specialty and tertiary care medical services. Since its establishment in 2015, the hospital has expanded its infrastructure and healthcare capabilities to serve patients across western Tamil Nadu with advanced diagnostics, specialized treatments, and comprehensive medical care.
Q.2Is Royal Care Super Specialty Hospital a listed or an unlisted company?
Royal Care Super Specialty Hospital is an unlisted company, meaning its shares are not traded on the National Stock Exchange (NSE) or Bombay Stock Exchange (BSE). Investors interested in owning its shares must purchase them through the unlisted share market, subject to availability.
Q.3How can I buy Royal Care Super Specialty Hospital unlisted shares?
You can purchase Royal Care Super Specialty Hospital unlisted shares through the private unlisted market. The process generally includes completing KYC verification, confirming the latest share price and availability, making the payment, and receiving the shares directly into your Demat account through an off-market transfer. It's advisable to review the company's financial performance and valuation before investing.
Q.4. How can I sell Royal Care Super Specialty Hospital shares?
If you own Royal Care Super Specialty Hospital shares, you can sell them through the unlisted market by finding an interested buyer. Once both parties agree on the price, the shares are transferred from the seller's Demat account to the buyer's account, and the payment is settled as per the agreed terms.
Q.5What is the minimum investment required for Royal Care Super Specialty Hospital shares?
There is no fixed minimum investment amount. The investment depends on the prevailing unlisted share price, the number of shares available, and the minimum quantity offered by the seller. Since prices in the unlisted market can fluctuate, investors should verify the latest details before making a purchase.
Q.6Is it legal to buy Royal Care Super Specialty Hospital unlisted shares in India?
Yes. Investing in Royal Care Super Specialty Hospital unlisted shares is legal in India when the transaction complies with applicable regulations. Shares should be transferred through a registered Demat account, and investors should ensure all documentation and payment procedures are completed properly.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
